Table 4.
Generalized models for the association of sentinel lymph node biopsy (SLNB) with specified outcome
Model description | Any complication | Lymphedema | Wound infection | Seroma | Pain |
---|---|---|---|---|---|
SLNB | |||||
No | REF | REF | REF | REF | REF |
Yes | 1.39 (1.18–1.63) | 4.45 (2.27–8.75) | 1.24 (1.00–1.54) | 1.40 (1.03–1.91) | 1.31 (1.04–1.65) |
Mastectomy after BCS | |||||
No | REF | REF | REF | REF | REF |
Yes | 1.36 (1.05–1.77) | 2.17 (0.98–4.82) | 1.55 (1.12–2.15) | 2.51 (1.60–3.92) | 0.88 (0.58–1.33) |
Radiotherapy | |||||
No | REF | REF | REF | REF | REF |
Yes | 0.85 (0.85–1.31) | 0.86 (0.44–1.68) | 0.81 (0.65–1.02) | 1.07 (0.76–1.51) | 0.85 (0.67–1.07) |
Prior MRI | |||||
No | REF | REF | REF | REF | REF |
Yes | 1.05 (0.72–1.00) | 1.30 (0.64–2.61) | 0.94 (0.70–1.25) | 1.82 (1.27–2.60) | 1.06 (0.78–1.44) |
Accounting for matching and adjusting for treatment received. Adjusted odds ratio (99% confidence interval)
MRI magnetic resonance imaging, BCS breast-conserving surgery